FIELD: medicine, pharmacy.
SUBSTANCE: invention relates to a method for treatment of vascular proliferation in a patient. Method involves administration of agonist of somatostatin receptor type 1 in the therapeutically effective dose to a patient wherein indicated agonist of somatostatin receptor type 1 show the inhibition constant value (Ki) lower 5 nM for somatostatin receptor type 1 and its Ki value for somatostatin receptor type 1 at least by 10 times lower as compared with Ki values for each somatostatin receptors type 2, type 3, type 4 and type 5. Invention provides the maximal inhibition of unfavorable vascular proliferation at minimal symptoms of adverse effects based on the selective anti-angiogenic effect of agonist of somatostatin receptor type 1.
EFFECT: valuable medicinal properties of compositions.
12 cl, 3 tbl, 16 dwg
Authors
Dates
2006-12-10—Published
2002-01-14—Filed